279 - Study Design of a Phase 3, Randomized, Open-Label, Multicenter Study to Evaluate Ruxolitinib Over BAT in Patients with Corticosteroid-Refractory Chronic Graft vs Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation (REACH-3)
| Autor: | Zeiser, Robert, Ram, Ron, Foley, Stephen Ronan, Yeshurun, Moshe, Locatelli, Franco, Artz, Andrew, Gadbaw, Brian, Atienza, Edric, Hollaender, Norbert, Delaite, Patricia, Teshima, Takanori |
|---|---|
| Zdroj: | In Biology of Blood and Marrow Transplantation March 2018 24(3) Supplement:S208-S208 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect